[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@VerEduard "@DesertDweller93 Correct it only changes the ST outlook. The CNPV will be a great PR for the FDA if it is granted to a therapy which impacts a larger swat of the population and which does not cost X mil a pop. Anyway $QURE is a great hold here"
X Link @VerEduard 2025-10-10T14:49Z XXX followers, XXX engagements

"@peter_mantas Ahhh $MRVI old known name to me. One of my longest bags. When it finally leaves my port I will probably suffer "empty nest" syndrome"
X Link @VerEduard 2025-10-09T19:54Z XXX followers, XXX engagements

"@DesertDweller93 What are the odds that a CNPV could happen for AMT-130 XX% max Meanwhile everyone is FOMOing on $QURE on X. Kind of understandable why some people may take the under. P.S. I am long with CB at XX and I don't see a CNPV as possible for this drug"
X Link @VerEduard 2025-10-10T11:39Z XXX followers, XXX engagements

"@SixSigmaCapital $CLPT company with interesting brain therapies and also enabler of genetic treatments such as the Uniqure AMT-130. They have around XX similar partnerships in the pipe"
X Link @VerEduard 2025-10-10T09:41Z XXX followers, XXX engagements

"@marketplunger1 Ivan Glasenberg says hello. #Glencore"
X Link @VerEduard 2025-10-12T18:15Z XXX followers, XXX engagements

"@INArteCarloDoss Could you venture a guess what will happen to the relationship between France and Germany I see only bad outcomes either way if Germans temporarily rescue France from its debt or if Germans say "nein""
X Link @VerEduard 2025-10-17T08:22Z XXX followers, 1316 engagements